SCHEMBL6948836

SCHEMBL6948836

COCCCCOC1(C)C=CC=CC1C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.35
KDM4E B2RXH2 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2216090 0.91
SCHEMBL20503228 0.87 PPARG (0.34)
SCHEMBL4101948 0.87 ALDH1A1 (0.31) ALDH1A1
SCHEMBL1989127 0.81
SCHEMBL498489 0.77
SCHEMBL29265338 0.73 ALDH1A1 (0.32) ALDH1A1
SCHEMBL5227293 0.73
SCHEMBL20740669 0.72 DHFR (0.43)
SCHEMBL1508735 0.69
Phenylacetaldehyde SCHEMBL6378611 0.69 CYP3A4 (0.36) ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003103652-A1 METHODS OF TREATING ALZHEIMER’S DISEASE USING AROMATICALLY SUBSTITUTED ω-AMINO-ALKANOIC ACID AMIDES AND ALKANOIC ACID DIAMIDES ELAN PHARMACEUTICALS, INC. (US) 2003-12-18 WO disclosed